Tag Archive | PrEP
(Reuters) – Nine US Democratic presidential candidates [appeared] at a televised town hall on Thursday focused on LGBT rights, though top contender, Bernie Sanders, [missed] the event as he recovers from a heart attack. The Los Angeles event is the second major presidential forum dedicated to LGBTQ issues during the Democratic nominating campaign, following an […]
(Reuters) The US Food and Drug Administration on Thursday approved Gilead Sciences Inc’s Descovy to reduce the risk of [HIV infection]. The approval does not include use of the drug by women to prevent HIV infection. Descovy, a combination drug, was approved in 2016 to treat people already infected with HIV. It contains a newer […]
It was a photograph that went around the world. The image of Britain’s Princess Diana shaking hands with AIDS patients at a London hospital in 1987 was hailed as a milestone in the battle against the stigma surrounding people with the virus. Yet more than three decades later, despite recent moves by television star, Jonathan […]
-by Ash Kotak On Saturday, former Wales rugby captain Gareth Thomas made a statement via Twitter which he began by saying: “I want to share my secret with you. Why? Because it’s mine to tell you. Not the evils that make my life hell, threatening to tell you before I do”.
Delays in rolling out an HIV prevention pill in Britain are putting gay men’s lives at risk, with thousands buying it online without medical supervision, HIV campaigners said on Wednesday. Britain is lagging behind the United States and Kenya, where the highly-effective drug is more widely available, as health authorities only give the pills to […]
(Reuters) – Gilead Sciences Inc hopes to soon introduce a pricey new pill to prevent HIV in people at risk of contracting the infection, but the drugmaker faces opposition from an unusual source – patient advocates. Such groups have traditionally lobbied for insurance coverage of newer HIV drugs, regardless of expense. But at least three […]
Health authorities in England said on Friday last that they support a plan to double to 26,000 the number of participants in an HIV prevention pill trial, ahead of a potential national roll-out. Demand for pre-exposure prophylaxis (PrEP) – a once-daily pill that is highly protective against HIV – has exceeded expectations, said National Health […]